Curanex Pharmaceuticals Inc
CURX Nasdaq
SEC CIK 2025942
Follow Curanex Pharmaceuticals
Weekly email: filings, results
Net income
−$2.8M
−195.1% vs same quarter last year
EPS, diluted
−$1.86
−148% vs same quarter last year
Operating cash flow
−$1.4M
+85.2% vs same quarter last year
Operating income
−$2.8M
−197.4% vs same quarter last year
Source: SEC XBRL filings · latest filing